Aloe vera |
inhibitory effects on CYP3A4 and CYP2D6; insulin-sensitizing effects |
increased efficacy: Pioglitazone and Repaglinide; additive effects with antidiabetics in general |
Andrographis paniculata |
inhibitory effects on CYP3A4 and CYP2C9 activities; enhanced glucose transport by glucose transporter 4 |
probably increased efficacy: Glibenclamide, Glimepiride, Nateglinide, Rosiglitazone; Pioglitazone, and Repaglinide; maybe additive effects with antidiabetics in general |
Ginseng |
induction of CYP3A4; stimulates insulin secretion |
probably decreased efficacy: Glibenclamide; Pioglitazone; Meglitinides; Sitagliptin, Saxagliptin; additive effects with antidiabetics |
Karela (Momordica charantia)
|
inhibition of CYP2C9; stimulates insulin secretion |
probably increased efficacy: Glibenclamide, glimepiride, nateglinide, and Rosiglitazone; additive effects with antidiabetics in general |
Lycium |
inhibition of CYP2C9; improved glucose transport and insulin signaling |
slightly increased efficacy (maybe): Glibenclamide, Glimepiride, Nateglinide, and Rosiglitazone; maybe additive effects with antidiabetics in general |
St John’s Wort |
induction of CYP3A4, 1A2, 2D6, 2E1; drug transporter: p-glycoprotein induced |
decreased efficacy. Sulfonylurea; Thiazolidinediones; Meglitinides; Sitagliptin (probably), Saxagliptin (probably) |
Herbs with Glucosamines |
increased insulin resistance |
may diminish antidiabetic efficacy |
Herbs with Isoflavones |
inhibitory effects on CYP2C9 and CYP3A4 |
probably increased efficacy: Glibenclamide, Glimepiride, Nateglinide, Rosiglitazone; Pioglitazone, and Repaglinide |
Herbs with Levocarnitine |
increased glucose oxidation |
additive effects with antidiabetics in general |